Jump to content

Name a Right Wing Position


Recommended Posts

The difference in health between democratic vs republican areas apparently is a real issue. I remember hearing about it recently on radio. I would think that as more laws impacting our health get shifted from federal level to state level, that the disparity in the health gap will widen. 

 

https://www.forbes.com/sites/madelinehalpert/2022/06/07/republican-counties-have-higher-mortality-rates-than-democratic-ones-study-finds/?sh=7fbeefb65c6a

 

https://www.npr.org/2022/06/13/1104529561/the-partisan-divide-can-undermine-americans-health-researchers-say

  • Like (+1) 1
  • Thank you (+1) 1
Link to comment
Share on other sites

  • Replies 1.1k
  • Created
  • Last Reply

Top Posters In This Topic

58 minutes ago, Andy1 said:

The difference in health between democratic vs republican areas apparently is a real issue. I remember hearing about it recently on radio. I would think that as more laws impacting our health get shifted from federal level to state level, that the disparity in the health gap will widen. 

 

https://www.forbes.com/sites/madelinehalpert/2022/06/07/republican-counties-have-higher-mortality-rates-than-democratic-ones-study-finds/?sh=7fbeefb65c6a

 

https://www.npr.org/2022/06/13/1104529561/the-partisan-divide-can-undermine-americans-health-researchers-say


Really makes it hard to believe the GOP actually is “pro-life” since they oppose policies that help people live. 

Link to comment
Share on other sites

54 minutes ago, ChiGoose said:


Really makes it hard to believe the GOP actually is “pro-life” since they oppose policies that help people live. 


They have selective outrage 

 

High Insulin cost = CAPITALISM

 

High gas prices = BRANDON‼️‼️‼️

  • Like (+1) 1
Link to comment
Share on other sites

2 hours ago, ChiGoose said:
 

‘MURICA!

 

 

 

 

ANOTHER ASPECT OF THE DEMOCRAT DISASTER: DRUG PRICE CONTROLS

 

 

We have not yet taken the measure of the disaster that is the Democrats’ “Inflation Reduction Act,” perhaps the most absurdly named statute ever. One element of the law that has not gotten enough attention is its imposition of price controls on pharmaceuticals. Price controls are always, and everywhere, a terrible idea. When you apply price controls to a vital product like drugs, the results could be catastrophic.

 

At Real Clear Policy, my colleague Peter Nelson, who worked at the Centers for Medicare & Medicaid Services in the Trump administration, where he was in charge of price transparency initiatives, explains:

 

I coauthored a new report with my colleague John Phelan at Center of the American Experiment which highlights how drug price controls would weaken the U.S. drug industry’s global leadership position and give China the opportunity to control greater market share to advance their national interests.

 

The package of price controls in the budget reconciliation bill would require Medicare to set prices for certain high-cost drugs and require drug manufacturers to pay rebates to the federal government when price increases exceed inflation. It uses the term “negotiation,” but it operates as a strict price control. That’s because excessive penalties on drug manufacturers for not negotiating make it a negotiation drug companies can’t refuse. Meanwhile, the inflation rebates impose price controls on nearly all drugs covered by Medicare Part D, as well as brand drugs and biologics covered by Medicare Part B.

 

Europe’s drug manufacturing industry used to be the global leader, but this leadership position eroded over the past three decades and the U.S. now stands on top.

 

Over the most recent five-year period from 2016 to 2020, the U.S. accounted for 138 of the new chemical and biological drug entities, followed by Europe at 64. Twenty years ago, Europe was on top.

 

The budget reconciliation bill’s strict price controls create a serious risk that the U.S. drug industry might follow in Europe’s footsteps.

 

To the benefit of–who else?–China. Much more at the link, and especially in the linked report.

 

 

 

https://www.powerlineblog.com/archives/2022/08/another-aspect-of-the-dem-disaster-drug-price-controls.php

 

https://www.realclearpolicy.com/articles/2022/08/05/drug_price_controls_will_embolden_china_at_your_expense_846562.html

 

https://files.americanexperiment.org/wp-content/uploads/2022/07/Drug-Pricing-Report-Final.pdf

 

 

 

 

.

Link to comment
Share on other sites

3 hours ago, B-Man said:

 

 

 

ANOTHER ASPECT OF THE DEMOCRAT DISASTER: DRUG PRICE CONTROLS

 

 

We have not yet taken the measure of the disaster that is the Democrats’ “Inflation Reduction Act,” perhaps the most absurdly named statute ever. One element of the law that has not gotten enough attention is its imposition of price controls on pharmaceuticals. Price controls are always, and everywhere, a terrible idea. When you apply price controls to a vital product like drugs, the results could be catastrophic.

 

At Real Clear Policy, my colleague Peter Nelson, who worked at the Centers for Medicare & Medicaid Services in the Trump administration, where he was in charge of price transparency initiatives, explains:

 

I coauthored a new report with my colleague John Phelan at Center of the American Experiment which highlights how drug price controls would weaken the U.S. drug industry’s global leadership position and give China the opportunity to control greater market share to advance their national interests.

 

The package of price controls in the budget reconciliation bill would require Medicare to set prices for certain high-cost drugs and require drug manufacturers to pay rebates to the federal government when price increases exceed inflation. It uses the term “negotiation,” but it operates as a strict price control. That’s because excessive penalties on drug manufacturers for not negotiating make it a negotiation drug companies can’t refuse. Meanwhile, the inflation rebates impose price controls on nearly all drugs covered by Medicare Part D, as well as brand drugs and biologics covered by Medicare Part B.

 

Europe’s drug manufacturing industry used to be the global leader, but this leadership position eroded over the past three decades and the U.S. now stands on top.

 

Over the most recent five-year period from 2016 to 2020, the U.S. accounted for 138 of the new chemical and biological drug entities, followed by Europe at 64. Twenty years ago, Europe was on top.

 

The budget reconciliation bill’s strict price controls create a serious risk that the U.S. drug industry might follow in Europe’s footsteps.

 

To the benefit of–who else?–China. Much more at the link, and especially in the linked report.

 

 

 

https://www.powerlineblog.com/archives/2022/08/another-aspect-of-the-dem-disaster-drug-price-controls.php

 

https://www.realclearpolicy.com/articles/2022/08/05/drug_price_controls_will_embolden_china_at_your_expense_846562.html

 

https://files.americanexperiment.org/wp-content/uploads/2022/07/Drug-Pricing-Report-Final.pdf

 

 

 

 

.


Hey, if you want to shill for big pharma, you go ahead and do that. Personally, I think that Americans should have access to life saving medicine if they need it. 

Link to comment
Share on other sites

10 hours ago, ChiGoose said:


Hey, if you want to shill for big pharma, you go ahead and do that. Personally, I think that Americans should have access to life saving medicine if they need it. 

 

 

No.

 

Information is information.

 

If it upsets your bias, then don't read it.

 

.

Link to comment
Share on other sites

The average American insulin user spent $3490 on insulin in 2018 compared with $725 among Canadians. Over the study period, the average cost per unit of insulin in the United States increased by 10.3% compared with only 0.01% in Canada. Feb 9, 2022

 

https://www.mayoclinicproceedings.org/article/S0025-6196(21)00883-1/fulltext#:~:text=The average American insulin user,with only 0.01% in Canada.

 

For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico.    Feb 12, 2019

Americans Cross Border Into Mexico To Buy Insulin At A Fraction Of U.S. Cost

 

The U.S. government estimates that close to 1 million people in California alone cross to Mexico annually for health care, including to buy prescription drugs. And between 150,000 and 320,000 Americans list health care as a reason for traveling abroad each year. Cost savings is the most commonly cited reason.

 

In Utah last year, the Public Employee Health Plan took this idea to a new level with its voluntary Pharmacy Tourism Program. For certain PEHP members who use any of 13 costly prescription medications — including the popular arthritis drug Humira — the insurer will foot the bill to fly the patient and a companion to San Diego, then drive them to a hospital in Tijuana, Mexico, to pick up a 90-day supply of medicine.

 


“The average cost of an eligible drug in the US is over $4,500 per month and is 40-60% less in Mexico,” PEHP clinical services director Travis Tolley said in an announcement of the program in October.

 

According to the Food and Drug Administration, “in most circumstances, it is illegal for individuals to import drugs into the United States for personal use.” But the agency’s website does provide guidance about when it could be allowed. And the U.S. Customs and Border Protection’s website has a whole section on traveling with medications in its “Know Before You Go” guide.

 

https://khn.org/news/americans-cross-border-into-mexico-to-buy-insulin-at-a-fraction-of-u-s-cost/#:~:text=For one patient%2C a three,U.S. versus %24600 in Mexico.

Link to comment
Share on other sites

  • 2 weeks later...
×
×
  • Create New...